Blood test guides extra treatment to stop Cancer's return
NCT ID NCT07371247
Summary
This study is testing a personalized approach to control advanced esophageal cancer. It uses a blood test to find patients at high risk of the cancer coming back after standard treatment. Those high-risk patients then receive extra treatment with immunotherapy and chemotherapy to try to prevent recurrence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangsu Province Hospital
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.